Thrombolytics: no survival benefit in patients aged > 75 years?

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2000

Schlagwörter:	Myocardial Infarction Survival Benefit Thrombolytic Therapy Thrombolytic Agent Reperfusion Therapy

Anmerkung:	© Adis International Ltd 2000

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1241(2000), 1 vom: Juni, Seite 15-15
Übergeordnetes Werk:	volume:1241 ; year:2000 ; number:1 ; month:06 ; pages:15-15

Links:	Volltext

DOI / URN:	10.2165/00128413-200012410-00037

Katalog-ID:	SPR036309885

Internformat


LEADER	01000caa a22002652 4500
001	SPR036309885
003	DE-627
005	20230519071334.0
007	cr uuu---uuuuu
008	201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200012410-00037 \|2 doi
035			\|a (DE-627)SPR036309885
035			\|a (SPR)00128413-200012410-00037-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Thrombolytics: no survival benefit in patients aged > 75 years?
264		1	\|c 2000
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2000
650		4	\|a Myocardial Infarction \|7 (dpeaa)DE-He213
650		4	\|a Survival Benefit \|7 (dpeaa)DE-He213
650		4	\|a Thrombolytic Therapy \|7 (dpeaa)DE-He213
650		4	\|a Thrombolytic Agent \|7 (dpeaa)DE-He213
650		4	\|a Reperfusion Therapy \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1241(2000), 1 vom: Juni, Seite 15-15 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1241 \|g year:2000 \|g number:1 \|g month:06 \|g pages:15-15
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200012410-00037 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1241 \|j 2000 \|e 1 \|c 06 \|h 15-15

Indexfelder

matchkey_str	article:22306056:2000----::hobltcnsriabnftnai
hierarchy_sort_str	2000
publishDate	2000
allfields	10.2165/00128413-200012410-00037 doi (DE-627)SPR036309885 (SPR)00128413-200012410-00037-e DE-627 ger DE-627 rakwb eng Thrombolytics: no survival benefit in patients aged > 75 years? 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1241(2000), 1 vom: Juni, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1241 year:2000 number:1 month:06 pages:15-15 https://dx.doi.org/10.2165/00128413-200012410-00037 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1241 2000 1 06 15-15
spelling	10.2165/00128413-200012410-00037 doi (DE-627)SPR036309885 (SPR)00128413-200012410-00037-e DE-627 ger DE-627 rakwb eng Thrombolytics: no survival benefit in patients aged > 75 years? 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1241(2000), 1 vom: Juni, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1241 year:2000 number:1 month:06 pages:15-15 https://dx.doi.org/10.2165/00128413-200012410-00037 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1241 2000 1 06 15-15
allfields_unstemmed	10.2165/00128413-200012410-00037 doi (DE-627)SPR036309885 (SPR)00128413-200012410-00037-e DE-627 ger DE-627 rakwb eng Thrombolytics: no survival benefit in patients aged > 75 years? 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1241(2000), 1 vom: Juni, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1241 year:2000 number:1 month:06 pages:15-15 https://dx.doi.org/10.2165/00128413-200012410-00037 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1241 2000 1 06 15-15
allfieldsGer	10.2165/00128413-200012410-00037 doi (DE-627)SPR036309885 (SPR)00128413-200012410-00037-e DE-627 ger DE-627 rakwb eng Thrombolytics: no survival benefit in patients aged > 75 years? 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1241(2000), 1 vom: Juni, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1241 year:2000 number:1 month:06 pages:15-15 https://dx.doi.org/10.2165/00128413-200012410-00037 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1241 2000 1 06 15-15
allfieldsSound	10.2165/00128413-200012410-00037 doi (DE-627)SPR036309885 (SPR)00128413-200012410-00037-e DE-627 ger DE-627 rakwb eng Thrombolytics: no survival benefit in patients aged > 75 years? 2000 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2000 Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1241(2000), 1 vom: Juni, Seite 15-15 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1241 year:2000 number:1 month:06 pages:15-15 https://dx.doi.org/10.2165/00128413-200012410-00037 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1241 2000 1 06 15-15
language	English
source	Enthalten in Inpharma weekly 1241(2000), 1 vom: Juni, Seite 15-15 volume:1241 year:2000 number:1 month:06 pages:15-15
sourceStr	Enthalten in Inpharma weekly 1241(2000), 1 vom: Juni, Seite 15-15 volume:1241 year:2000 number:1 month:06 pages:15-15
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Myocardial Infarction Survival Benefit Thrombolytic Therapy Thrombolytic Agent Reperfusion Therapy
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2000-06-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036309885
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036309885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519071334.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012410-00037</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036309885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012410-00037-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thrombolytics: no survival benefit in patients aged > 75 years?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Survival Benefit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombolytic Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombolytic Agent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reperfusion Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1241(2000), 1 vom: Juni, Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1241</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012410-00037</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1241</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Thrombolytics: no survival benefit in patients aged > 75 years? Myocardial Infarction (dpeaa)DE-He213 Survival Benefit (dpeaa)DE-He213 Thrombolytic Therapy (dpeaa)DE-He213 Thrombolytic Agent (dpeaa)DE-He213 Reperfusion Therapy (dpeaa)DE-He213
topic	misc Myocardial Infarction misc Survival Benefit misc Thrombolytic Therapy misc Thrombolytic Agent misc Reperfusion Therapy
spellingShingle	misc Myocardial Infarction misc Survival Benefit misc Thrombolytic Therapy misc Thrombolytic Agent misc Reperfusion Therapy Thrombolytics: no survival benefit in patients aged > 75 years?
topic_unstemmed	misc Myocardial Infarction misc Survival Benefit misc Thrombolytic Therapy misc Thrombolytic Agent misc Reperfusion Therapy
topic_browse	misc Myocardial Infarction misc Survival Benefit misc Thrombolytic Therapy misc Thrombolytic Agent misc Reperfusion Therapy
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Thrombolytics: no survival benefit in patients aged > 75 years?
ctrlnum	(DE-627)SPR036309885 (SPR)00128413-200012410-00037-e
title_full	Thrombolytics: no survival benefit in patients aged > 75 years?
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2000
contenttype_str_mv	txt
container_start_page	15
container_volume	1241
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200012410-00037
title_sort	thrombolytics: no survival benefit in patients aged > 75 years?
title_auth	Thrombolytics: no survival benefit in patients aged > 75 years?
abstract	© Adis International Ltd 2000
abstractGer	© Adis International Ltd 2000
abstract_unstemmed	© Adis International Ltd 2000
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Thrombolytics: no survival benefit in patients aged > 75 years?
url	https://dx.doi.org/10.2165/00128413-200012410-00037
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200012410-00037
up_date	2024-07-03T16:59:35.096Z
_version_	1803577956862263296
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036309885</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519071334.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2000 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200012410-00037</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036309885</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200012410-00037-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thrombolytics: no survival benefit in patients aged > 75 years?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2000</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2000</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Myocardial Infarction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Survival Benefit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombolytic Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thrombolytic Agent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reperfusion Therapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1241(2000), 1 vom: Juni, Seite 15-15</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1241</subfield><subfield code="g">year:2000</subfield><subfield code="g">number:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:15-15</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200012410-00037</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1241</subfield><subfield code="j">2000</subfield><subfield code="e">1</subfield><subfield code="c">06</subfield><subfield code="h">15-15</subfield></datafield></record></collection>
score	7.398802

Nicht das Richtige dabei?

Schreiben Sie uns!

Thrombolytics: no survival benefit in patients aged > 75 years?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?